GlaxoSmithKline Pakistan Limited (PSX:GLAXO)
Pakistan
· Delayed Price · Currency is PKR 325.66
-15.26 (-4.48%)
At close: Mar 6, 2026
GlaxoSmithKline Pakistan Ratios and Metrics
Market cap in millions PKR. Fiscal year is January - December.
Millions PKR. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 5, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Market Capitalization | 103,712 | 126,403 | 26,430 | 27,952 | 43,474 | 61,092 | Upgrade
|
| Market Cap Growth | -20.20% | 378.26% | -5.45% | -35.70% | -28.84% | 19.47% | Upgrade
|
| Enterprise Value | 97,072 | 119,878 | 22,631 | 20,591 | 38,013 | 57,102 | Upgrade
|
| Last Close Price | 325.66 | 383.52 | 80.19 | 84.81 | 125.34 | 168.99 | Upgrade
|
| PE Ratio | 11.29 | 19.34 | 49.50 | 11.35 | 8.12 | 18.10 | Upgrade
|
| PS Ratio | 1.67 | 2.07 | 0.53 | 0.67 | 1.19 | 1.74 | Upgrade
|
| PB Ratio | 3.49 | 4.47 | 1.22 | 1.33 | 2.07 | 3.50 | Upgrade
|
| P/TBV Ratio | 3.60 | 4.63 | 1.28 | 1.39 | 2.17 | 3.71 | Upgrade
|
| P/FCF Ratio | 23.69 | 55.38 | 112.68 | - | 11.80 | 13.15 | Upgrade
|
| P/OCF Ratio | 14.53 | 24.99 | 14.03 | - | 8.72 | 10.25 | Upgrade
|
| EV/Sales Ratio | 1.56 | 1.96 | 0.46 | 0.49 | 1.04 | 1.63 | Upgrade
|
| EV/EBITDA Ratio | 5.98 | 10.57 | 7.85 | 3.48 | 4.98 | 10.09 | Upgrade
|
| EV/EBIT Ratio | 6.51 | 11.69 | 11.52 | 4.06 | 5.53 | 11.63 | Upgrade
|
| EV/FCF Ratio | 22.18 | 52.52 | 96.49 | - | 10.32 | 12.30 | Upgrade
|
| Debt / Equity Ratio | 0.01 | 0.01 | 0.03 | 0.02 | 0.01 | 0.02 | Upgrade
|
| Debt / EBITDA Ratio | 0.02 | 0.03 | 0.25 | 0.06 | 0.04 | 0.07 | Upgrade
|
| Debt / FCF Ratio | 0.08 | 0.16 | 3.09 | - | 0.08 | 0.08 | Upgrade
|
| Net Debt / Equity Ratio | -0.22 | -0.22 | -0.13 | -0.21 | -0.40 | -0.32 | Upgrade
|
| Net Debt / EBITDA Ratio | -0.41 | -0.54 | -1.00 | -0.75 | -1.10 | -1.00 | Upgrade
|
| Net Debt / FCF Ratio | -1.52 | -2.69 | -12.30 | 0.94 | -2.29 | -1.22 | Upgrade
|
| Asset Turnover | 1.26 | 1.47 | 1.35 | 1.27 | 1.30 | 1.42 | Upgrade
|
| Inventory Turnover | 2.40 | 3.95 | 4.30 | 4.20 | 4.24 | 4.48 | Upgrade
|
| Quick Ratio | 0.84 | 1.17 | 0.83 | 0.92 | 1.41 | 1.13 | Upgrade
|
| Current Ratio | 1.88 | 2.06 | 1.74 | 1.82 | 2.28 | 2.04 | Upgrade
|
| Return on Equity (ROE) | 33.41% | 26.17% | 2.50% | 11.72% | 27.84% | 20.08% | Upgrade
|
| Return on Assets (ROA) | 18.97% | 15.40% | 3.33% | 9.60% | 15.20% | 12.45% | Upgrade
|
| Return on Invested Capital (ROIC) | 39.07% | 31.26% | 2.72% | 16.74% | 40.71% | 26.72% | Upgrade
|
| Return on Capital Employed (ROCE) | 46.90% | 34.00% | 8.30% | 22.40% | 31.10% | 26.30% | Upgrade
|
| Earnings Yield | 8.86% | 5.17% | 2.02% | 8.81% | 12.32% | 5.53% | Upgrade
|
| FCF Yield | 4.22% | 1.81% | 0.89% | -16.79% | 8.47% | 7.60% | Upgrade
|
| Dividend Yield | 3.07% | 2.61% | - | - | 5.58% | 3.85% | Upgrade
|
| Payout Ratio | 51.61% | 0.03% | 345.56% | 15.23% | 38.51% | 56.04% | Upgrade
|
| Total Shareholder Return | 3.07% | 2.61% | - | - | 5.58% | 3.85% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.